-
effectivehealthcare.ahrq.gov/products/autism/research-protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-256-telehealth-women-preventive-services-executive-summary.pdf
June 01, 2022 - Harms Interactive online tool Noninteractive online tool 1 RCT (231) No difference in patient reported anxiety
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism-update_disposition-comments.pdf
August 06, 2014 - interaction-based
interventions, joint attention interventions, and cognitive
behavior therapy (CBT) for anxiety … sleep
problems, elopement (wandering), pica (ingesting inedible
items), behaviors associated with anxiety … The first sentence says that “five of six
RTCs identified in the literature measured anxiety
symptoms … The fact that we now that the anxiety studies
included 5 RTCs is useful information and this type of … outcomes targeted
(e..g, p. 33 ...interventions targeting symptoms commonly
associated with ASD such as anxiety
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-257-antenatal-care-disposition-comments.pdf
June 28, 2022 - , there was insufficient evidence for
several of the stated outcomes of interest, such as maternal anxiety
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-1-nonopioid-pharm-chronic-pain.pdf
April 01, 2022 - found no
differences in pain improvement
and pain response between the
two formulations; sleep, anxiety … pregabalin associated with
improved pain, pain response,
and sleep interference but no
improvement in anxiety … between pregabalin formulations on DPRS 30 and 50 percent
pain reduction, sleep, and depression or anxiety … interference (p<0.001).9 There was also no
difference between pregabalin versus placebo on the Hospital Anxiety … and Depression Scale
(HADS) anxiety scale, but pregabalin was associated with improved HADS depression
-
effectivehealthcare.ahrq.gov/sites/default/files/tech-brief-37-opiod-use-adults-comments.pdf
November 03, 2020 - Summary and
Implications
More detail needed on anxiety as predictor:
PTSD? … , psychological trauma history, pain-
related anxiety? … It is not clear
that we should specifically call out tobacco
(or anxiety).
KI Reviewer 1 f. … history of) tobacco use, “substance misuse,”
and duration of anxiety/depression. … ● The role of home or facility
monitoring of older adults and
anxiety reduction.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-262-pharmacotherapy-alcohol-summary.pdf
November 01, 2023 - Compared with placebo, study participants treated with acamprosate were more
likely to experience anxiety … events, including paresthesias, taste
abnormalities, anorexia, difficulty with concentration/attention, nervousness
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/gestational-diabetes-screening-diagnosis_research-protocol.pdf
December 16, 2011 - Tests with poor performance
may result in patient stress, anxiety, and unnecessary investigation and … and oral hypoglycemic agents
Comparators: Placebo or no treatment
Outcomes: Harms, including anxiety … KQ5 addresses harms, including anxiety, healthcare system issues, burden
on practitioner’s office,
-
effectivehealthcare.ahrq.gov/sites/default/files/mcda-ijzerman.pdf
January 01, 2011 - Sexual dysfunction
o Other adverse events
• Disease specific QoL points to:
o Social function
o Anxiety
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/deficit-hyperactivity-protocol.pdf
November 01, 2021 - A
particular challenge is separating ADHD from other conditions that may appear similar
(e.g., anxiety … also can lead to incorrectly
diagnosing as ADHD other conditions that share symptoms with ADHD (e.g., anxiety … socioeconomic
status, race and ethnicity, prior trauma history, co-occurring conditions (e.g., depression
or anxiety … They are also at risk for future depression, anxiety, suicide attempts, and
problematic peer and family … for residential
placement)
o Obesity, tobacco use, substance abuse, mood
disorders, depression or anxiety
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/unpublished-drug-trials-white-paper.pdf
December 01, 2024 - the reporting of harms in clinical
trials of second-generation antidepressants
for depression and anxiety … Depress Anxiety. 2016;33(3):247-55.
doi: 10.1002/da.22477. PMID: 26882293.
19.
-
effectivehealthcare.ahrq.gov/products/mental-health-pregnancy/protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/insomnia_clinician.pdf
August 01, 2017 - Hypnotics
Eszopiclone Somnolence, unpleasant
taste in the mouth,
headache, dizziness, dry
mouth, rash, anxiety … paresthesias,
difficulty with coordination
Benzodiazepines Temazepam Drowsiness, dizziness,
headache, nervousness
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/point-of-care_research.pdf
April 01, 2014 - Comparative effectiveness of second-generation
antidepressants for accompanying anxiety,
insomnia, … Depress Anxiety. 2012
Jun;29(6):495-505. PMID 22553134.
43. … Comparative
effectiveness of second-generation antidepressants for
accompanying anxiety, insomnia, … Depression and anxiety. 2012;29(6):495-505.
Morgan L, Gartlehner G. … Depression and anxiety. 2012;29(6):495-505.
c. Morgan L, Gartlehner G.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-emergency_disposition-comments.pdf
November 27, 2012 - Anxiety is NOT equivalent to mood change,
moodiness. … Peer Reviewer
#9
Clarity and usability Anxiety includes insomnia—this is not necessarily an anxiety-related … metocholrpropamide, or
perchlorpromazine or droperidol is likely to benefit. if there are features of
hysteria, anxiety
-
effectivehealthcare.ahrq.gov/sites/default/files/nt_docs/topic-brief-updating-pharmacotherapy.pdf
September 30, 2022 - disease, diabetes mellitus, liver cirrhosis,
pancreatitis, various malignancies, as well as depression, anxiety … , tingling)
• metabolic acidosis
• glaucoma
• vision changes
• suicidal ideation
• insomnia
• anxiety … the treatment of AUD varied by presence of comorbid post-
traumatic stress disorder, depression, and anxiety … Coadministration of Disulfiram and Lorazepam in
the treatment of alcohol dependence and co-occurring anxiety
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-229-opioid-treatments-chronic-pain-evidence-summary.pdf
April 01, 2020 - opioids vs. nonopioids in SF-36 mental health
status (6 trials, N=1427), sleep (7 trials, N=1694), anxiety … (3 trials, N=414)
or depression (7 trials, N=748) at short-term followup (SOE: low for anxiety,
moderate … an opioid alone in mean
improvement in SF-36 measures of physical or mental health status, sleep, anxiety … discontinuation, or opioid dose through up to 4 years of
followup; cannabis use was associated with increased anxiety
-
effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-antenatal-care.pdf
April 01, 2021 - pre-eclampsia, mental health
outcomes)
Maternal mortality
Quality of life outcomes including stress and
anxiety … pre-eclampsia, mental health
outcomes)
Maternal mortality
Quality of life outcomes including stress and
anxiety
-
effectivehealthcare.ahrq.gov/products/depression-brain-injury/research-protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/screening-counseling-interventions-executive-summary.pdf
April 01, 2025 - • No studies were identified that focused on the implementation of screening for
anxiety, screening … based on race and ethnicity.20
We did not identify any studies on implementation of screening for anxiety